Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
ABM
0.00%
0.0¢
RBS ALTERNATIVE INVESTMENTS (AUSTRALIA) PTY LTD
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ABM | Ann: SFI Distribution For Warrants Over STW Jun 2017 Final | 18:57 | 3 | 1.8K | |||
|
|||||||
ABM | Ann: Warrants Delisting AGLSZC 29 June 2017 | 29/06/17 | 0 | 436 | |||
|
|||||||
ABM | Ann: SYDSZC Dividend Early Expiry Announcement 29 June 17 | 29/06/17 | 0 | 500 | |||
|
|||||||
ABM | Ann: SFI Distribution For Warrants Over STW Jun 2017 Estimated | 28/06/17 | 0 | 382 | |||
|
|||||||
ABM | Ann: SFI Distribution For Warrants Over SYD Jun 2017 | 28/06/17 | 0 | 1.1K | |||
|
|||||||
ABM | Ann: SFI Distribution For Warrants Over CIMIC Group Ltd Jun 2017 | 08/06/17 | 0 | 467 | |||
|
|||||||
ABM | Ann: SFI Distribution For Warrants Over WBC May 2017 | 09/05/17 | 0 | 438 | |||
|
|||||||
ABM | Ann: SFI Distribution For Warrants Over MQG May 2017 | 09/05/17 | 0 | 466 | |||
|
See All Discussions